Special Issue "Molecular Genetics of Neuropsychiatric Diseases"
Deadline for manuscript submissions: 8 March 2024 | Viewed by 6834
Psychiatric diseases, such as schizophrenia, bipolar disorder and autism spectrum disorder, are devastating brain disorders with a major unmet therapeutic need. The high degree of heritability suggests that inherited genetic variants contribute to the etiology of schizophrenia and autism and lead to early developmental perturbations. Recently, substantial progress has identified over one hundred gene loci associated with schizophrenia, bipolar disorder and autism. These findings have raised a hope of being able to use human genetics to uncover new drug targets and to develop novel treatment paradigms. However, molecular functions and genetic interactions of many newly identified risk genes in the nervous system are completely unknown. The insight into the potential mechanisms underlying the genetic risks of these disorders could potentially revolutionize our approach to the diagnosis and treatment of these complex mental illnesses.
This Special Issue entitled “Molecular Genetics of Neuropsychiatric Diseases” welcomes original research and reviews on studying new genetic risk factors associated with or linked to different psychiatric disorders. The SI will focus on mechanistic studies of the risk genes on proliferation and differentiation of neural stem cells, cell fate determination, neuronal maturation, migration during neurodevelopment, behavioral regulation and therapeutic intervention using different animal models and human iPSCs. Other novel studies that help to better understand the etiology of psychiatric illness are also welcome.
We are looking forward to your contributions to this Special Issue.
Dr. Yingwei Mao
Dr. Xin Tang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Psychiatric disease
- Bipolar disorder
- Genetic risk